Who is sponsoring NCT03710512?

NCT03710512 is sponsored by Universitair Ziekenhuis Brussel.

What drugs are being tested in NCT03710512?

Interventions in NCT03710512: Bilateral sagittal split osteotomy.

What condition does NCT03710512 study?

NCT03710512 studies Mandibular Hypoplasia, Relapse.

Is NCT03710512 still recruiting?

NCT03710512 is currently status unknown. Last updated 18 October 2018.

Last reviewed 2018-10-18 · How we verify

NCT03710512

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Early Relapse After Mandibular Lengthening Surgery

Status unknown Last updated 18 October 2018

What this trial tests

trial testing Bilateral sagittal split osteotomy in Mandibular Hypoplasia in 50 participants. Status unknown.

Timeline

11 September 2018

Primary endpoint
1 September 2019

30 December 2019

Quick facts

Lead sponsor	Universitair Ziekenhuis Brussel
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	11 September 2018
Primary completion	1 September 2019
Estimated completion	30 December 2019
Sites	1 location across Belgium

Drugs / interventions tested

Bilateral sagittal split osteotomy

Conditions studied

Mandibular Hypoplasia — all drugs for Mandibular Hypoplasia →
Relapse — all drugs for Relapse →

Sponsor

Universitair Ziekenhuis Brussel — full company profile →

Who can join

Adults 10 to 75, any sex, with Mandibular Hypoplasia or Relapse. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to evaluate whether the use of a bone graft substitute at the osteotomy site will result in better stability and diminish early relapse after mandibular lengthening surgery. The study focuses on the evaluation of the following hypothesis: The use of bone graft substitute at the osteotomy site has an influence on: * The 3-dimensional stability of the osteotomy site * Early relapse based in the plasticity of the site

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Universitair Ziekenhuis Brussel trials

Trials by the same sponsor.

NCT07536230 — Deep Learning Framework for Continuous Depth of Anesthesia Forecasting · not yet recruiting
NCT07533968 — The Aim of This Study is to Gain Insight Into the Occurrence of Irritable Bowel Symptoms During Ovarian Stimulation in I · NA · not yet recruiting
NCT07289984 — Correlation Between Diagnostic Nerve Block Response and Cryoneurolysis Outcome in Chronic Musculoskeletal Disorders and · NA · not yet recruiting
NCT06923813 — Assessment of Nutrient Absorption in Enterally Fed Post-intensive Care Unit Patients Using Bomb Calorimetry: do the Calo · NA · recruiting
NCT07401004 — Effect of Blink-Based Training on Cancer Detection in Colorectal Polyp Images by Medical Students/Non GI-trainees · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03710512 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitair Ziekenhuis Brussel
Last refreshed: 18 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03710512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing